Limmi Disease Insights Platform to be used in university hospital setting to improve detection of kidney stone disease recurrence
CARLSBAD, Calif., Jan. 16, 2024 /PRNewswire/ -- Limmi, a startup specializing in Artificial Intelligence and Data Insights for life sciences, today announced it will be using Limmi's disease insights platform in hospitals with an initial focus on kidney stone disease recurrence.
- CARLSBAD, Calif., Jan. 16, 2024 /PRNewswire/ -- Limmi, a startup specializing in Artificial Intelligence and Data Insights for life sciences, today announced it will be using Limmi's disease insights platform in hospitals with an initial focus on kidney stone disease recurrence.
- Limmi's Disease Insights Platform has been meticulously designed to address the common challenges researchers face when dealing with large sets of data, particularly complex health data.
- "We know that recurring kidney stones affect approximately 50% of patients—but we don't have a personalized risk predictor for individual patients.
- We have fortunately collected years of high quality kidney stone patient data to apply to Artificial Intelligence (AI).